Analyst ratings
22 analysts have weighed in: a Strong Buy consensus: 22 buy calls against 0 sell, with an average 12-month price target of $196.18.
NASDAQ: INSM · Biotechnology
Over the past week, Insmed (INSM) pulled in 9 mentions across Reddit, X and news, and the read is an Adanos Hold. That is too little tracked discussion to read a direction from, so the signal stays neutral. Wall Street is more constructive, with 22 of 22 analysts rating INSM a buy.
Tracked discussion on INSM is too thin this week to read a direction from, which is why it reads as a Hold.
Wall Street’s 100% buy share sits next to a crowd that ranges from Reddit at 0% to X at 100%. No other tracker puts the two side by side.
22 analysts have weighed in: a Strong Buy consensus: 22 buy calls against 0 sell, with an average 12-month price target of $196.18.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week INSM carries too few tracked mentions to weigh any of them, so the read is Hold rather than a clear buy or sell.
Analysts sit 61 points above the crowd average of 39%, the professionals are more constructive than retail. The split is inside the crowd: X reads 100% bullish while Reddit sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Insmed (INSM) buzz held subdued around 29.6 while the price drifted up 2.1% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.4M shares. Updated Jul 27, 2026. Over the last 7 trading days, INSM held roughly flat. Buzz activity in the recent week averaged 31.0 and was relatively stable, swinging between 29.0 and 33.8. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 9 of the 16 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for INSM and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live INSM sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 27, 2026.
Adanos will not call Insmed (INSM) either way right now. The last 7 days carry 9 tracked mentions across 3 sources, under the 10-mention floor, so the signal sits at a neutral hold with 40/100 conviction. This is a sentiment-based reading, not financial advice.
Reddit discussion around Insmed (INSM) is fairly quiet with 2 mentions across 1 tracked subreddits. The tone is 0% bullish with stable 3-day activity momentum, suggesting steady attention.
There is not enough tracked discussion on Insmed (INSM) to call it either way. The last 7 days carry 9 tracked mentions across 3 sources, under the 10-mention floor Adanos needs before it reads a direction. On the professional side, 22 of 22 analysts rate INSM a buy.
Of the 22 analysts covering Insmed (INSM), 22 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $196.18. That puts the street ahead of the crowd, which averages 39% bullish.
Insmed (INSM) does not carry enough tracked discussion this week to have a readable sentiment. 9 mentions across 3 sources is under the 10-mention floor, so the signal stays neutral at 40/100 conviction.
Not for a reason found in the sentiment itself. Insmed (INSM) drew 9 tracked mentions in the last 7 days, too small a sample to read a direction from, so Adanos holds the signal neutral instead of calling a buy or sell off it.
News is the dominant discussion channel with 6 mentions (67% of total volume). Reddit contributes 2 mentions and X contributes 1 mention. There is too little of it to read a sentiment direction from.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. INSM's hold signal at 40/100 conviction reflects a sample too thin to read a direction from. It is a research shortcut, not financial advice.
The INSM sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Insmed with similar bullish ratios, signal direction and discussion volume. All 6 peers carry hold signals, pointing to broad mixed pressure rather than an INSM-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key